Altium Capital Management LP Bria Cell Therapeutics Corp. Transaction History

Altium Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$4.4 - $9.28 $3.52 Million - $7.43 Million	-800,295 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.89 - $6.57 $2.31 Million - $5.26 Million	800,295 New	800,295 $4.27 Million

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $11.8M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.